All Episodes
The Rheumatology Podcast — 137 episodes
Dr Vanessa Smith on simple capillaroscopic definitions to describe capillary morpholog
Air pollution and RA flares
Precision medicine in autoimmune diseases
Trainee Publishing Programme 2021: Aimie Patience
Chetan Mukhtyar on the long-term use of tocilizumab in giant cell arteritis
Prof Raphaèle Seror on smoking status and the risk of incident RA
Wolfgang Schmidt on the use of ultrasound in diagnosing and managing giant cell arteritis (GCA)
RA patient access to DMARDs in Norway
Results from the NEIAA Short Report on Ethnicity
Dr David Fajgenbaum on cytokine storm syndromes
Rheumatology Podcast - Bernard Lauwerys
Dr John Hanly on lupus nephritis
BSR myositis guideline: What does this mean for patients?
BSR myositis guideline: Clinical updates
Improving outcomes for hospitalised gout patients
Safety and clinical activity of atacicept in SLE
BSR guidelines on axial spondyloarthritis
Treating IgG4-related disease with rituximab
Prof Jon Giles - Muscle mass relative to fat mass with physical function in RA
Dr Steven Zhao on comorbidities and disease activity in axSpA
De novo lupus nephritis and belimumab
Trainee Publishing Programme 2021: Dr Sreejitha Sreevilasan
Comparing IgG and IgG + IgM anti-dsDNA assays
Biomarkers for paediatric cytokine storm syndromes
Prof. Frances Williams on chronic widespread pain and the gut microbiome
Dr. Iona Thorne on reproductive health in women with rheumatic disease
Julie Paik on tofacitinib monotherapy in the treatment of calcinosis in refractory DM
Dr. Sara Booth on employment practice and SLE
Dr Chris Rooney on the gut microbiome and rheumatoid arthritis
Dr Gouri Koduri on patient perceptions of comorbidities
Mark McClure on prediction models in ANCA-associated vasculitis
Learning and lessons from the EUVAS case report supplement
Dr Peter Grayson on VEXAS syndrome
Prof. Paul Emery on COVID-19 vaccination and antirheumatic therapy
Comparing and contrasting RA ILD and IPF
NEIAA: Predicting disease activity in early inflammatory arthritis
Dr Alfred Kim on non-adherence and physician-patient interactions in SLE
Prof. Elaine Yacyshyn and Dr Whitney Hung on checkpoint inhibitor-induced GPA
Foot and ankle care in people with rheumatoid arthritis
Dr Ioannis Parodis on BMI and health-related quality of life in SLE
Dr Josep Ribalta on the atherogenic effect of LDL on endothelial cells
Dr Elizabeth Price on the upcoming BSR Sjögren’s syndrome guideline
Dr Matthew Basiaga on classifying and diagnosing paediatric Sjögren’s syndrome
Retrospectively reviewing polymyositis diagnoses in a large single-centre cohort
Dr Rosemary Hollick on telephone-based CBT in axSpA
Dr Fiona Pearce on the risk of death among RAIRD patients during the COVID-19 pandemic
Dr Filipa Farinha on membranous and proliferative lupus nephritis
Dr Neil Basu on the effect of anti-TNF therapy on fatigue in ax-SpA
Dr Carlos Fernández-Díaz on abatacept in RA ILD
Dr William Tillett and Dr Laura Coates on the upcoming BSR PsA guideline
Dr Deva Situnayake on Behçet's disease and the THIN database
Dr Lewis Carpenter on clinical markers and patient-reported outcomes in early RA
Md Yuzaiful Md Yusof on infection and drug survival from the use of biological therapies in RA-associated bronchiectasis
Dr Philip Hamann on RA trajectories, real world data and AI
Dr Mrinalini Dey and Dr Kathrine Grøn discuss infection risk in RA
Dr Marwan Bukhari and Dr Kanta Kumar discuss COVID-19 and ethnicity
Dr Steven Zhao and Dr Cristina Maglio discuss bariatric surgery and rheumatoid arthritis
Dr Chris Wincup and Dr Elena Nikiphorou discuss methotrexate and interstitial lung disease in RA
Dr Marwan Bukhari talks to Prof Danieli Andrade about pregnancy outcomes in mixed connective tissue disease
Dr Marwan Bukhari talks to Dr Hannah Jethwa about transforming rheumatology services post-COVID-19
Dr Marwan Bukhari talks to Dr Eline Houben about cardiovascular risk factors in ANCA-associated vasculitis
Dr Marwan Bukhari talks to Dr Philipp Bosch about measuring disease activity in PsA using ultrasound
Dr Marwan Bukhari discusses PET/CT scans in relapsing polychondritis with Dr Aman Sharma
Dr Chris Wincup talks to Dr Giacomo De Luca about the use of apremilast in Behçet’s disease.
Dr Marwan Bukhari talks to Professor John McBeth on sensitisation fatigue
Dr Marwan Bukhari talks to Dr Helena Marzo-Ortega on the use of MRI in the diagnosis of axSpA
Dr Marwan Bukhari talks to Dr Harsha Gunawardena
Dr Abhishek Abhishek on his recent paper on the Gout Activity Score
Dr Carly Janssen on care for acute gout flares and measures in clinical trials
Prof Kimme Hyrich on her work on Rheumatology’s real-world data supplement
Dr Matthew J. Koster on the diagnosis, monitoring and management of large-vessel GCA
Dr Laura Cappelli on shared epitope alleles and immune checkpoint inhibitor-induced inflammatory arthritis
Dr Sujith Subesinghe on biologic prescribing decisions following serious infection in RA patients
Dr Chris Holroyd on the updated BSR biologic DMARD safety guidelines in inflammatory arthritis
Marwan Bukhari and Associate Editor, Xenofon Baraliakos, on what he looks for in a paper
Dr Andrew Filer on the role of ultrasound-defined tenosynovitis
Dr Susan Goodman on management of perioperative TNFα inhibitors
Dr Faith Matcham on the relationship between depression and biologic treatment response in rheumatoid arthritis
Dr Edward Roddy on the recently conducted gout audit
Prof Yoshiya Tanaka on strategic treatment of psoriatic arthritis patients
Prof. Jacques Morel on risk factors of serious infections in patients with RA treated with tocilizumab
Dr Karl Gaffney on the BSR and BHPR guideline for the treatment of axial spondyloarthritis
Dr Helena Andersson on long-term experience with rituximab
Colour duplex sonography in the routine care of GCA
Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus
BSR guideline for the management of systemic lupus erythematosus in adults
BSR and BHPR guideline for the prescription and monitoring of non-biologic DMARDS
Twitter, #alternativefacts, careless whispers and Rheumatology
BSR Guideline for the Management of Gout
Management of Sjögren's Syndrome
Rheumatology Podcast - Lars Erik Kristensen
Rheumatology Podcast - Astrid van Tubergen
Rheumatology podcast episode 44
Guidance for the treatment of systemic sclerosis – July 2016
Guidance on prescribing drugs in pregnancy and breastfeeding – May 2016
Relapse and treatment outcomes in biopsy-proven giant cell arteritis - March 2016
Effect of allopurinol on all-cause mortality in adults with incident gout: propensity score–matched landmark analysis - February 2016
Fast-track ultrasound clinic for early diagnosis of GCA - December 2015
Vasculitis associated with RA - July 2014
Change at the top - February 2014
Treatment for antiphospholipid antibodies – Jan 2014
The evolution of RA treatment: Will we find the cure? – Jan 2014
A new kidney-specific diagnostic marker to assess disease activity in lupus nephritis - Dec 2013
Managing patients with early RA - July 2013
Systemic sclerosis: subsets and diagnosis - July 2013
New molecules for the treatment of rheumatoid arthritis - July 2013
Epigenetics and autoimmune disease - July 2013
Frequency of anti-infliximab antibodies: patients with RA in routine care – (May 2013)
Uric acid-lowering therapy: treatment of gout – (April 2013)
Role of patients in the management of RA – (January 2013)
Cardiovascular risk in ankylosing spondylitis – (December 2012)
MRI of joints in children – (November 2012)
Keeping pace with changes in vasculitis – (August 2012)
Physical activity in RA patients – (June 2012)
Evidence for use of complementary medicine in RA – (June 2012)
Ultrasound guided steroid injections in children – (May 2012)
Psoriatic arthritis and a placebo controlled RCT- (April 2012)
ANCA-associated vasculitis- (March 2012)
BSR and BHPR guidelines on the use of rituximab – (Feb 2012)
Inflammatory myopathies - (June 2011)
Early Rheumatoid Arthritis treatment strategies - (June 2011)
Patient perceptions - (June 2011)
Cohorts in rheumatoid arthritis - (May 2011)
50th Anniversary: A perspective on the past - (March 2011)
Registries - (January 2011)
Is rheumatoid arthritis a genetically distinct subset? - (September 2010)
Factors predictive of thrombotic events in SLE patients - (August 2010)
Spondyloarthropathies: Ankylosing spondylitis with and without concomitant psoriasis - (July 2010)
Increase in ferritin levels and interstitial lung disease in dermatomyositis - (May 2010)
Cost of using TNF-alpha inhibitors - (April 2010)
Cardiovascular disease and rheumatoid arthritis: what is the link? - (March 2010)
Hypermobility in children - (February 2010)
The role of biomarkers in the treatment of rheumatoid arthritis - (January 2010)
Rheumatoid arthritis in elderly patients - (December 2009)
Active rheumatoid arthritis - (November 2009)
Management of Systemic Sclerosis - (July 2009)
Antiphospholipid antibody syndrome - (June 2009)